Trial Profile
Addition of a purine analogue (cladribine or fludarabine) to induction regimen in patients with acute myeloid leukaemia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jun 2012
Price :
$35
*
At a glance
- Drugs Cladribine (Primary) ; Fludarabine (Primary) ; Cytarabine; Daunorubicin
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 16 Apr 2012 Results published in the Journal of Clinical Oncology.
- 05 Nov 2010 New trial record.